Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
STAT+
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Politics
STAT+

Under fire from Trump, drug industry lands Oval Office meeting on Tuesday

By Dylan Scott Jan. 30, 2017

Reprints
Donald Trump
Donald Trump at the Jan. 11 news conference where he said drug companies were "getting away with murder." Spencer Platt/Getty Images

WASHINGTON — Representatives from the drug industry’s top lobbying group will head to the White House Tuesday morning for a rendezvous with President Trump.

Steve Ubl, president and CEO of the Pharmaceutical Research and Manufacturers of America, and several of PhRMA’s board members will meet with Trump and Vice President Mike Pence at 9 a.m. in the Oval Office.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Dylan Scott

Washington Correspondent

Tags

Alphabet’s laid-off health tech employees on where their work…
Alphabet’s laid-off health tech employees on where their work heads next
Medicare Advantage insurers to repay billions under final federal…
Medicare Advantage insurers to repay billions under final federal audit rule
‘Everybody has blood on their hands’: A decade-long battle…
‘Everybody has blood on their hands’: A decade-long battle over Medicare Advantage audits is coming to…
Medicare may test policy of paying less for accelerated…
Medicare may test policy of paying less for accelerated approval drugs
Pharmalittle: Amgen pricing for Humira biosimilar may not help…
Pharmalittle: Amgen pricing for Humira biosimilar may not help patients; pharma wins court battle over drug…
Amgen pricing for its Humira biosimilar may benefit PBMs…
Amgen pricing for its Humira biosimilar may benefit PBMs and insurers more than patients

Comments are closed.

Recommended Stories